<DOC>
	<DOCNO>NCT01100203</DOCNO>
	<brief_summary>Patients Chronic Kidney Disease ( CKD ) poor prognosis primarily due cardiovascular disease . The cardiovascular risk assess measurement arterial stiffness . A decrease stiffness show decrease risk cardiovascular disease well death . Most CKD population also hypertension control blood pressure one corner stone inhibition disease progression . Using drug specifically block renin-angiotensin-system blood pressure control show beneficial impact inhibition progression beyond achieve blood pressure control . It report inhibition hormone aldosterone positive effect survival patient heart failure , hypertension diabetic well on-diabetic nephropathy . This study undertake investigation influence arterial stiffness add aldosterone receptor inhibitor medication CKD patient already take . Besides primary end point Pulse wave velocity ( PWV ) , arterial stiffness also quantify thorough ambulatory blood pressure measurement .</brief_summary>
	<brief_title>Aldosterone Blockade Chronic Kidney Disease : Influence Arterial Stiffness Kidney Function</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<criteria>≥ 18 year age ≤ 80 year age voluntarily sign informed consent 15 ml/min/1,73 m2 ≤ estimate Glomerular Filtration Rate &lt; 60 ml/min/1,73 m2 BP ≥ 130/80 mmHg undergoing antihypertensive treatment ppotassium &gt; 5.0 mM allergy content treat spironolactone treat potent inhibitor CYP3A4 ( see SPC detail ) treat lithium , ciclosporin , tacrolimus , prednisolone , immunosuppressing drug inborn error metabolism ( see SPC detail ) pregnancy lactation fertile woman , use safe contraception device dementia psychiatric disorder , make understanding study condition impossible severe , chronic illness besides CKD , include liver insufficiency , accord investigator ' judgement vascular surgery include stenting graft implantation a. brachialis , aorta carotid artery systolic BP &gt; 200 mmHg immeasurable pulse amplitude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>aldosterone receptor inhibition</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>ambulatory arterial stiffness index</keyword>
</DOC>